Arbidol hydrochloride is primarily used for the prevention and treatment of influenza A and B viruses and other acute viral respiratory infections, including severe acute respiratory syndrome with complications such as bronchitis and pneumonia; it significantly shortens the duration of influenza, alleviates symptoms (e.g., cough, headache, fever, chills, sweating, sore throat, myalgia, and fatigue), and prevents the development of post-influenza complications; it is also effective in prophylaxis during influenza outbreaks or for high-risk individuals exposed to infected patients; additionally, in vitro studies suggest potential efficacy against SARS virus and avian influenza virus.